Cargando…
The potential for isotope dilution-LC-MS/MS to improve laboratory measurement of C-peptide: Reasons and critical determinants
Human C-peptide is secreted in equimolar amounts with insulin by pancreatic beta-cells. Measurement of C-peptide plays an important role in the diagnosis and treatment of diabetes where it is used to evaluate the function of islet cells. However, C-peptide measurement results across different labora...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600993/ https://www.ncbi.nlm.nih.gov/pubmed/34820671 http://dx.doi.org/10.1016/j.jmsacl.2021.07.001 |
_version_ | 1784601259426185216 |
---|---|
author | Deng, Yuhang Zhao, Haijian Liu, Qingxiang Zhou, Weiyan Zhang, Chuanbao |
author_facet | Deng, Yuhang Zhao, Haijian Liu, Qingxiang Zhou, Weiyan Zhang, Chuanbao |
author_sort | Deng, Yuhang |
collection | PubMed |
description | Human C-peptide is secreted in equimolar amounts with insulin by pancreatic beta-cells. Measurement of C-peptide plays an important role in the diagnosis and treatment of diabetes where it is used to evaluate the function of islet cells. However, C-peptide measurement results across different laboratories vary considerably and there is an urgent need to improve comparability between laboratories. As it is sensitive and specific, isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS) has made a major contribution and will continue to play a significant role in the standardization of C-peptide measurement. Here, we reviewed the application of ID-LC-MS/MS in C-peptide measurement by discussing the biochemical properties of C-peptide, common sample preparation procedures, and the sensitivity problems often encountered with ID-LC-MS/MS C-peptide measurement. Collectively, these factors are crucial for the development of ID-LC-MS/MS methods for C-peptide measurement. We also discussed the advantages, disadvantages, and progress of implementing ID-LC-MS/MS as a routine measurement tool for C-peptide in clinical laboratories. Finally, we summarized the existing reference system and the status of C-peptide measurement in clinical laboratories to convey the necessity of improving the comparability of C-peptide measurement in clinical laboratories using ID-LC-MS/MS. |
format | Online Article Text |
id | pubmed-8600993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-86009932021-11-23 The potential for isotope dilution-LC-MS/MS to improve laboratory measurement of C-peptide: Reasons and critical determinants Deng, Yuhang Zhao, Haijian Liu, Qingxiang Zhou, Weiyan Zhang, Chuanbao J Mass Spectrom Adv Clin Lab Special issue on Clinical mass spectrometry in China Human C-peptide is secreted in equimolar amounts with insulin by pancreatic beta-cells. Measurement of C-peptide plays an important role in the diagnosis and treatment of diabetes where it is used to evaluate the function of islet cells. However, C-peptide measurement results across different laboratories vary considerably and there is an urgent need to improve comparability between laboratories. As it is sensitive and specific, isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS) has made a major contribution and will continue to play a significant role in the standardization of C-peptide measurement. Here, we reviewed the application of ID-LC-MS/MS in C-peptide measurement by discussing the biochemical properties of C-peptide, common sample preparation procedures, and the sensitivity problems often encountered with ID-LC-MS/MS C-peptide measurement. Collectively, these factors are crucial for the development of ID-LC-MS/MS methods for C-peptide measurement. We also discussed the advantages, disadvantages, and progress of implementing ID-LC-MS/MS as a routine measurement tool for C-peptide in clinical laboratories. Finally, we summarized the existing reference system and the status of C-peptide measurement in clinical laboratories to convey the necessity of improving the comparability of C-peptide measurement in clinical laboratories using ID-LC-MS/MS. Elsevier 2021-08-03 /pmc/articles/PMC8600993/ /pubmed/34820671 http://dx.doi.org/10.1016/j.jmsacl.2021.07.001 Text en © 2021 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Special issue on Clinical mass spectrometry in China Deng, Yuhang Zhao, Haijian Liu, Qingxiang Zhou, Weiyan Zhang, Chuanbao The potential for isotope dilution-LC-MS/MS to improve laboratory measurement of C-peptide: Reasons and critical determinants |
title | The potential for isotope dilution-LC-MS/MS to improve laboratory measurement of C-peptide: Reasons and critical determinants |
title_full | The potential for isotope dilution-LC-MS/MS to improve laboratory measurement of C-peptide: Reasons and critical determinants |
title_fullStr | The potential for isotope dilution-LC-MS/MS to improve laboratory measurement of C-peptide: Reasons and critical determinants |
title_full_unstemmed | The potential for isotope dilution-LC-MS/MS to improve laboratory measurement of C-peptide: Reasons and critical determinants |
title_short | The potential for isotope dilution-LC-MS/MS to improve laboratory measurement of C-peptide: Reasons and critical determinants |
title_sort | potential for isotope dilution-lc-ms/ms to improve laboratory measurement of c-peptide: reasons and critical determinants |
topic | Special issue on Clinical mass spectrometry in China |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600993/ https://www.ncbi.nlm.nih.gov/pubmed/34820671 http://dx.doi.org/10.1016/j.jmsacl.2021.07.001 |
work_keys_str_mv | AT dengyuhang thepotentialforisotopedilutionlcmsmstoimprovelaboratorymeasurementofcpeptidereasonsandcriticaldeterminants AT zhaohaijian thepotentialforisotopedilutionlcmsmstoimprovelaboratorymeasurementofcpeptidereasonsandcriticaldeterminants AT liuqingxiang thepotentialforisotopedilutionlcmsmstoimprovelaboratorymeasurementofcpeptidereasonsandcriticaldeterminants AT zhouweiyan thepotentialforisotopedilutionlcmsmstoimprovelaboratorymeasurementofcpeptidereasonsandcriticaldeterminants AT zhangchuanbao thepotentialforisotopedilutionlcmsmstoimprovelaboratorymeasurementofcpeptidereasonsandcriticaldeterminants AT dengyuhang potentialforisotopedilutionlcmsmstoimprovelaboratorymeasurementofcpeptidereasonsandcriticaldeterminants AT zhaohaijian potentialforisotopedilutionlcmsmstoimprovelaboratorymeasurementofcpeptidereasonsandcriticaldeterminants AT liuqingxiang potentialforisotopedilutionlcmsmstoimprovelaboratorymeasurementofcpeptidereasonsandcriticaldeterminants AT zhouweiyan potentialforisotopedilutionlcmsmstoimprovelaboratorymeasurementofcpeptidereasonsandcriticaldeterminants AT zhangchuanbao potentialforisotopedilutionlcmsmstoimprovelaboratorymeasurementofcpeptidereasonsandcriticaldeterminants |